Earnings Feed
Start Free
Home/Insiders/BAKER DOUGLAS P
BD
SEC Insider//CIK 0001028775

BAKER DOUGLAS P

CIK 00010287752 companiesAUSTIN,, TX
SEC Profile

Transactions

50

Companies

2

Filings

9

CIK

0001028775

Recent Transactions

50 trades
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-10-05$84.22/sh−4,000→ 34,796 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-10-05$7.51/sh−10,000→ 34,699 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-10-05$7.51/sh+10,000→ 44,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-10-05$82.35/sh−10,000→ 34,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-09-28$74.66/sh−2,000→ 38,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-09-21$70.59/sh−4,000→ 40,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-09-14$65.57/sh−3,768→ 44,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-09-08$67.25/sh−10,000→ 48,564 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-09-08$7.51/sh−10,000→ 44,699 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-09-08$7.51/sh+10,000→ 58,564 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-09-07$70.53/sh−2,232→ 48,564 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-08-31$66.62/sh−4,000→ 50,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-08-24$61.50/sh−4,000→ 54,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-08-20$58.45/sh−5,000→ 58,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-08-17$58.46/sh−4,000→ 63,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-08-13$63.27/sh−5,000→ 67,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-08-10$64.50/sh−2,000→ 72,796 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-08-09$7.51/sh+10,000→ 74,796 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-08-09$7.51/sh−10,000→ 54,699 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-08-09$64.31/sh−10,000→ 64,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-08-03$54.93/sh−2,000→ 74,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-07-27$52.58/sh−3,000→ 76,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-07-20$50.90/sh−3,000→ 79,796 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-07-08$2.46/sh+13,435→ 82,796 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-07-08−13,435→ 64,699 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-07-08$56.05/sh−13,435→ 69,361 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-06-28$63.00/sh−3,421→ 82,796 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-06-24$60.00/sh−4,000→ 86,217 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock (pursuant to 10B5-1 plan)

    2021-06-07$52.62/sh−14,500→ 75,717 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-06-07$2.46/sh+14,500→ 90,217 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-06-07−14,500→ 78,134 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock

    2021-05-18$45.85/sh−14,500→ 75,717 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-05-18−14,500→ 92,634 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-05-18$2.46/sh+14,500→ 90,217 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-01-29$7.51/sh+4,315→ 90,217 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock

    2021-01-29$47.25/sh−5,032→ 85,902 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-01-29$7.51/sh−4,315→ 107,134 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-01-13$7.51/sh−5,000→ 96,993 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-01-13$7.51/sh+5,000→ 90,937 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock

    2021-01-13$38.89/sh−5,000→ 85,937 total
  • Award
    OptimizeRx Corp$OPRX

    Stock Option

    2021-01-07+14,456→ 116,449 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock

    2021-01-04$32.88/sh−8,334→ 82,371 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-01-04$7.51/sh−4,000→ 101,993 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2021-01-04$2.46/sh−4,566→ 105,993 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-01-04$2.46/sh+4,566→ 86,937 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2021-01-04$7.51/sh+4,000→ 90,937 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Common Stock

    2020-11-12$2.46/sh+15,000→ 90,705 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2020-11-12$2.46/sh−15,000→ 110,559 total
  • Sale
    OptimizeRx Corp$OPRX

    Common Stock

    2020-11-11$24.05/sh−15,000→ 75,705 total
  • Exercise/Conversion
    OptimizeRx Corp$OPRX

    Stock Option

    2020-09-02$2.46/sh−10,000→ 125,559 total

Companies

2

Recent Filings

9

Address

3006 LONGHORN BLVD., SUITE 107

AUSTIN,, TX, 78758

View on SEC.gov